The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Oxidative stress in prostate cancer
Open accessAbstract
As prostate cancer and aberrant changes in reactive oxygen species (ROS) become more common with aging, ROS signaling may play an important role in the development and progression of this malignancy. Increased ROS, otherwise known as oxidative stress, is a result of either increased ROS generation or a loss of antioxidant defense mechanisms. Oxidative stress is associated with several pathological conditions including inflammation and infection. ROS are products of normal cellular metabolism and play vital roles in stimulation of signaling pathways in response to changing intra- and extracellular environmental conditions. Chronic increases in ROS over time are known to induce somatic mutations and neoplastic transformation. In this review we summarize the causes for increased ROS generation and its potential role in etiology and progression of prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McCord, J. M., & Fridovich, I. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63504-5 · Cited by 12,952
Oxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413
Aging: a theory based on free radical and radiation chemistry
Harman, D. (1956) · Journal of Gerontology · doi:10.1093/geronj/11.3.298 · Cited by 8,567
The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today
Doll, R., & Peto, R. (1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/66.6.1192 · Cited by 3,927 · cited 1×
“In recent years several antioxidant trails have been conducted against prostate cancer, but the usefulness of such therapies needs extensive research before put into practice [16].”
BackgroundHuggins, C., & Hodges, C. V. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64820-3 · Cited by 3,855
The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today
Peto, R. (1983) · The Use of Human Cells for the Evaluation of Risk from Physical and Chemical Agents · doi:10.1007/978-1-4757-1117-2_30 · Cited by 3,501
Hayes, J. D., & Pulford, D. J. (1995) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239509083491 · Cited by 3,464
NOX enzymes and the biology of reactive oxygen
Lambeth, J. D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1312 · Cited by 3,125
Production of large amounts of hydrogen peroxide by human tumor cells.
Szatrowski, T. P., & Nathan, C. (1991) · PubMed · Cited by 3,007
The Development of Human Benign Prostatic Hyperplasia with Age
Berry, S. J., Coffey, D. S., Walsh, P. C., & Ewing, L. L. (1984) · Journal of Urology · doi:10.1016/s0022-5347(17)49698-4 · Cited by 2,488
Harman, D. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.7124 · Cited by 1,915
Inflammation in prostate carcinogenesis
De Marzo, A. M., Platz, E. A., Sutcliffe, S., Xu, J., Grönberg, H., Drake, C. G., Nakai, Y., Isaacs, W. B., & Nelson, W. G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2090 · Cited by 1,621
NIH Consensus Definition and Classification of Prostatitis
Krieger, J. N., Nyberg, Jr., & Nickel, J. C. (1999) · JAMA · doi:10.1001/jama.282.3.236 · Cited by 1,473
ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis
Ishikawa, K., Takenaga, K., Akimoto, M., Koshikawa, N., Yamaguchi, A., Imanishi, H., Nakada, K., Honma, Y., & Hayashi, J.-I. (2008) · Science · doi:10.1126/science.1156906 · Cited by 1,444
(2005) · JAMA · doi:10.1001/jama.293.11.1338 · Cited by 1,209 · cited 1×
“These studies did not provide strong support for population-wide implementation of high dose antioxidant supplementation for the prevention of prostate cancer [18–20].”
BackgroundLee, I.-M., Cook, N. R., Gaziano, J. M., Gordon, D., Ridker, P. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · JAMA · doi:10.1001/jama.294.1.56 · Cited by 1,137
Curcumin and cancer: An “old-age” disease with an “age-old” solution
Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.025 · Cited by 1,132
Reactive Oxygen Species as Intracellular Messengers During Cell Growth and Differentiation
Sauer, H., Wartenberg, M., & Hescheler, J. (2001) · Cellular Physiology and Biochemistry · doi:10.1159/000047804 · Cited by 1,118
Imaging of angiogenesis: from microscope to clinic
McDonald, D. M., & Choyke, P. L. (2003) · Nature Medicine · doi:10.1038/nm0603-713 · Cited by 1,016
Heinonen, O. P., Koss, L., Albanes, D., Taylor, P. R., Hartman, A. M., Edwards, B. K., Virtamo, J., Huttunen, J. K., Haapakoski, J., Malila, N., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.6.440 · Cited by 918
Guzy, R. D., & Schumacker, P. T. (2006) · Experimental Physiology · doi:10.1113/expphysiol.2006.033506 · Cited by 881
mtDNA mutations increase tumorigenicity in prostate cancer
Petros, J. A., Baumann, A. K., Ruiz-Pesini, E., Amin, M. B., Sun, C. Q., Hall, J., Lim, S., Issa, M. M., Flanders, W. D., Hosseini, S. H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408894102 · Cited by 836
WARBURN, O., & DICKENS, F. (1931) · The American Journal of the Medical Sciences · doi:10.1097/00000441-193107000-00022 · Cited by 808
Infections as a major preventable cause of human cancer
Kuper, H., Adami, H. ‐., & Trichopoulos, D. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00742.x · Cited by 740
Oxidative Stress Is Inherent in Prostate Cancer Cells and Is Required for Aggressive Phenotype
Kumar, B., Koul, S., Khandrika, L., Meacham, R. B., & Koul, H. K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5259 · Cited by 736
Self-citationMolecular genetics of prostate cancer
Abate-Shen, C., & Shen, M. M. (2000) · Genes & Development · doi:10.1101/gad.819500 · Cited by 735
Rajah, R., Valentinis, B., & Cohen, P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.12181 · Cited by 722
Huggins, C., & Hodges, C. V. (2002) · Journal of Urology · doi:10.1016/s0022-5347(02)80307-x · Cited by 716
Nox enzymes, ROS, and chronic disease: An example of antagonistic pleiotropy
Lambeth, J. D. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.027 · Cited by 679
Mansfield, K. D., Guzy, R. D., Pan, Y., Young, R. M., Cash, T. P., Schumacker, P. T., & Simon, M. C. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.003 · Cited by 606
Armstrong, J. S., Steinauer, K. K., Hornung, B., Irish, J. M., Lecane, P., Birrell, G. W., Peehl, D. M., & Knox, S. J. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400959 · Cited by 507
Risk Factors for Prostate Cancer
Pienta, K. J., & Esper, P. S. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-10-199305150-00007 · Cited by 490
Reactive oxygen generated by Nox1 triggers the angiogenic switch
Arbiser, J. L., Petros, J., Klafter, R., Govindajaran, B., McLaughlin, E. R., Brown, L. F., Cohen, C., Moses, M., Kilroy, S., Arnold, R. S., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022630199 · Cited by 489
Epidemiologic association between prostatitis and prostate cancer
Dennis, L. K., Lynch, C. F., & Torner, J. C. (2002) · Urology · doi:10.1016/s0090-4295(02)01637-0 · Cited by 403
Prostate carcinogenesis and inflammation: emerging insights
Palapattu, G. S., Sutcliffe, S., Bastian, P. J., Platz, E. A., De Marzo, A. M., Isaacs, W. B., & Nelson, W. G. (2005) · Carcinogenesis · doi:10.1093/carcin/bgh317 · Cited by 388
THE ROLE OF INFLAMMATION IN THE PATHOGENESIS OF PROSTATE CANCER
NELSON, W. G., DE MARZO, A. M., DeWEESE, T. L., & ISAACS, W. B. (2004) · Journal of Urology · doi:10.1097/01.ju.0000142058.99614.ff · Cited by 386
ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage
Barzilai, A. (2002) · DNA Repair · doi:10.1016/s1568-7864(01)00007-6 · Cited by 359
Fernandez-Checa, J. C., Kaplowitz, N., Garcia-Ruiz, C., Colell, A., Miranda, M., Mari, M., Ardite, E., & Morales, A. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.1.g7 · Cited by 333
Increased Nox1 and hydrogen peroxide in prostate cancer
Lim, S. D., Sun, C., Lambeth, J. D., Marshall, F., Amin, M., Chung, L., Petros, J. A., & Arnold, R. S. (2005) · The Prostate · doi:10.1002/pros.20137 · Cited by 319
Prooxidant-Antioxidant Shift Induced by Androgen Treatment of Human Prostate Carcinoma Cells
Ripple, M. O., Wilding, G., Henry, W. F., & Rago, R. P. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.1.40 · Cited by 309
Hypoxia signalling controls metabolic demand
Brahimi-Horn, M. C., Chiche, J., & Pouysségur, J. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.003 · Cited by 298
Olinski, R., Gackowski, D., Foksinski, M., Rozalski, R., Roszkowski, K., & Jaruga, P. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00878-x · Cited by 283
Costello, L. C., Liu, Y., Franklin, R. B., & Kennedy, M. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.28875 · Cited by 267
WEI, Y., LU, C., LEE, H., PANG, C., & MA, Y. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09899.x · Cited by 265
NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells
Brar, S. S., Corbin, Z., Kennedy, T. P., Hemendinger, R., Thornton, L., Bommarius, B., Arnold, R. S., Whorton, A. R., Sturrock, A. B., Huecksteadt, T. P., et al. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00525.2002 · Cited by 260
Zoubeidi, A., Zardan, A., Beraldi, E., Fazli, L., Sowery, R., Rennie, P., Nelson, C., & Gleave, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2057 · Cited by 256
THE BIOLOGY OF HORMONE REFRACTORY PROSTATE CANCER
Isaacs, J. T. (1999) · Urologic Clinics of North America · doi:10.1016/s0094-0143(05)70066-5 · Cited by 251
Regulation of Reactive Oxygen Species and Genomic Stability in Hematopoietic Stem Cells
Naka, K., Muraguchi, T., Hoshii, T., & Hirao, A. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2114 · Cited by 244
MtDNA mutations in aging and apoptosis
Chomyn, A., & Attardi, G. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00625-9 · Cited by 243
Juul, A., Main, K., Blum, W. F., Lindholm, J., Ranke, M. B., & Skakkebaek, N. E. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb03788.x · Cited by 232
Scholl, S. M., Pallud, C., Beuvon, F., Hacene, K., Stanley, E. R., Rohrschneider, L., Tang, R., Pouillart, P., & Lidereau, R. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.2.120 · Cited by 226
Supplemental and Dietary Vitamin E, β-Carotene, and Vitamin C Intakes and Prostate Cancer Risk
Kirsh, V. A., Hayes, R. B., Mayne, S. T., Chatterjee, N., Subar, A. F., Dixon, L. B., Albanes, D., Andriole, G. L., Urban, D. A., & Peters, U. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj050 · Cited by 226
Costello, L. C., Liu, Y., Zou, J., & Franklin, R. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17499 · Cited by 224
Ricke, W. A., McPherson, S. J., Bianco, J. J., Cunha, G. R., Wang, Y., & Risbridger, G. P. (2008) · The FASEB Journal · doi:10.1096/fj.07-9526com · Cited by 213
Reactive oxygen species and HIF-1 signalling in cancer
Galanis, A., Pappa, A., Giannakakis, A., Lanitis, E., Dangaj, D., & Sandaltzopoulos, R. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.028 · Cited by 208
An integrated theory of aging as the result of mitochondrial-DNA mutation in differentiated cells
Miquel, J. (1991) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(91)90022-i · Cited by 197
The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis
Frohlich, D. A., McCabe, M. T., Arnold, R. S., & Day, M. L. (2008) · Oncogene · doi:10.1038/onc.2008.79 · Cited by 192
Androgenic Regulation of Oxidative Stress in the Rat Prostate
Tam, N. N. C., Gao, Y., Leung, Y.-K., & Ho, S.-M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63606-1 · Cited by 188
Activation of the Neutrophil Respiratory Burst Oxidase
Clark, R. A. (1999) · The Journal of Infectious Diseases · doi:10.1086/513849 · Cited by 173
Zhu, M., & Fahl, W. E. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5944 · Cited by 148
Espey, M. G., Miranda, K. M., Thomas, D. D., Xavier, S., Citrin, D. E., Vitek, M. P., & Wink, D. A. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04068.x · Cited by 148
Wang, Y., Kreisberg, J. I., & Ghosh, P. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907781662248 · Cited by 143
Altered metabolism and mitochondrial genome in prostate cancer
Dakubo, G. D., Parr, R. L., Costello, L. C., FRANKLIN, R. B., & Thayer, R. E. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.027664 · Cited by 135
Endocrine control of prostate cancer.
Wilding, G. (1995) · PubMed · Cited by 132
BelAiba, R. S., Djordjevic, T., Bonello, S., Flügel, D., Hess, J., Kietzmann, T., & Görlach, A. (2004) · Biological Chemistry · doi:10.1515/bc.2004.019 · Cited by 126
Chen, J. Z., Gökden, N., Greene, G. F., Mukunyadzi, P., & Kadlubar, F. F. (2002) · PubMed · Cited by 125
Cancer of the prostate: A nutritional disease?
Fair, W. R., Fleshner, N. E., & Heston, W. D. W. (1997) · Urology · doi:10.1016/s0090-4295(97)00339-7 · Cited by 124
Inflammation, atrophy, and prostate carcinogenesis
Marzo, A. M. D., Nakai, Y., & Nelson, W. G. (2007) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.05.007 · Cited by 123
Tumor-Associated Macrophages as Targets for Cancer Therapy
Wahl, L. M., & Kleinman, H. K. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.21.1583 · Cited by 110 · cited 1×
“opment of a cancer [110,111].”
Diet, Androgens, Oxidative Stress and Prostate Cancer Susceptibility
Fleshner, N. E., & Klotz, L. H. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1006118628183 · Cited by 109
Oxidative Stress, Cell Activation and Viral Infection
Pasquier, C., Olivier, R. Y., Auclair, C., & Packer, L. (1994) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7424-3 · Cited by 101
Growth factors and epithelial-stromal interactions in prostate cancer development
Wong, Y. C., & Wang, Y. Z. (2000) · International review of cytology · doi:10.1016/s0074-7696(00)99002-8 · Cited by 99
Baltacı, S., Orhan, D., Göğüş, Ç., Türkölmez, K., Tulunay, Ö., & Göğüş, O. (2001) · British Journal of Urology · doi:10.1046/j.1464-410x.2001.02231.x · Cited by 98
Wartenberg, M., Hoffmann, E., Schwindt, H., Grünheck, F., Petros, J. A., Arnold, J., Hescheler, J., & Sauer, H. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.06.078 · Cited by 98
Expression of ERα and ERβ in prostate cancer
Linja, M. J., Savinainen, K., Tammela, T. L. J., Isola, J. J., & Visakorpi, T. (2003) · The Prostate · doi:10.1002/pros.10242 · Cited by 97
Zhou, Q., Liu, L.-Z., Fu, B., Hu, X., Shi, X., Fang, J., & Jiang, B. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl085 · Cited by 97
Expression of proinflammatory genes during estrogen-induced inflammation of the rat prostate
Harris, M. T., Feldberg, R. S., Lau, K., Lazarus, N. H., & Cochrane, D. E. (2000) · The Prostate · doi:10.1002/1097-0045(20000615)44:1<19::aid-pros3>3.0.co;2-s · Cited by 95
Fu, V. X., Dobosy, J. R., Desotelle, J. A., Almassi, N., Ewald, J. A., Srinivasan, R., Berres, M. E., Svaren, J. P., Weindruch, R. H., & Jarrard, D. F. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1714 · Cited by 91
Zone-Dependent Expression of Estrogen Receptors α and β in Human Benign Prostatic Hyperplasia
Tsurusaki, T., Aoki, D., Kanetake, H., Inoue, S., Muramatsu, M., Hishikawa, Y., & Koji, T. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021015 · Cited by 88
Hormone Resistance in Prostate Cancer
Pilat, M. J., Kamradt, J. M., & Pienta, K. J. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1006166511344 · Cited by 78
Krishnan, A. V., Moreno, J., Nonn, L., Swami, S., Peehl, D. M., & Feldman, D. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.07s213 · Cited by 74
Prolactin and testosterone regulation of mitochondrial zinc in prostate epithelial cells
Liu, Y., FRANKLIN, R. B., & Costello, L. C. (1997) · The Prostate · doi:10.1002/(sici)1097-0045(19970101)30:1<26::aid-pros4>3.0.co;2-j · Cited by 70
Chronic bacterial prostatitis: An evolving clinical enigma
Nickel, J. C., & Moon, T. (2005) · Urology · doi:10.1016/j.urology.2004.12.028 · Cited by 70
Mitogen Activated Protein kinase signal transduction pathways in the prostate
MARONI, P. D., Koul, S., Meacham, R. B., & Koul, H. K. (2004) · Cell Communication and Signaling · doi:10.1186/1478-811x-2-5 · Cited by 70
Self-citationAsirvatham, A. J., Schmidt, M. A., Gao, B., & Chaudhary, J. (2005) · Endocrinology · doi:10.1210/en.2005-0942 · Cited by 63
Shigemura, K., Sung, S., Kubo, H., Arnold, R. S., Fujisawa, M., Gotoh, A., Zhau, H. E., & Chung, L. W. K. (2007) · The Prostate · doi:10.1002/pros.20565 · Cited by 58
Mehraein‐Ghomi, F., Lee, E., Church, D. R., Thompson, T. A., Basu, H. S., & Wilding, G. (2008) · The Prostate · doi:10.1002/pros.20737 · Cited by 53
Dietary influences on endocrine–inflammatory interactions in prostate cancer development
Ho, E., Boileau, T. W.-M., & Bray, T. Μ. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.01.009 · Cited by 50
Untergasser, G., Rumpold, H. F., Hermann, M., Dirnhofer, S., Jilg, G., & Berger, P. (1999) · Experimental Gerontology · doi:10.1016/s0531-5565(98)00063-1 · Cited by 48
Chen, J. Z., Gökden, N., Greene, G., Green, B., & Kadlubar, F. F. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg102 · Cited by 48
Mechanisms of prostate cancer progression to androgen independence
McPhaul, M. J. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.02.006 · Cited by 40
Block, K. L., Ricono, J. M., Lee, D., Bhandari, B., Choudhury, G. G., Abboud, H. E., & Gorin, Y. C. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1497 · Cited by 35
Redox Control of Gene Expression by Eukaryotic Transcription Factors NF-κB, AP-1 and SRF/TCF
Meyer, M., Schreck, R., Müller, J. M., & Baeuerle, P. A. (1994) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7424-3_20 · Cited by 32
Activity and content of antioxidant enzymes in prostate tumors.
Kotrikadze, N., Alibegashvili, M., Zibzibadze, M., Abashidze, N., Chigogidze, T., Managadze, L., & Arcivadze, K. (2008) · PubMed · Cited by 31
Development of Rat Prostatitis Model by Oral Administration of Isoflavone and Its Characteristics
Kwon, S. M., Kim, S. I., Chun, D. C., Cho, N. H., Chung, B. C., Park, B. W., & Hong, S. J. (2001) · Yonsei Medical Journal · doi:10.3349/ymj.2001.42.4.395 · Cited by 29
Pathak, S., Singh, R., Verschoyle, R. D., Greaves, P., Farmer, P. B., Steward, W. P., Mellon, J. K., Gescher, A. J., & Sharma, R. A. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.11.015 · Cited by 28
Bourdeau-Heller, J. M., & Oberley, T. D. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21069 · Cited by 14
Cited by
Oxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies
Rani, V., Deep, G., Singh, R. K., Palle, K., & Yadav, U. C. S. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.002 · Cited by 1,139
Molecular genetics of prostate cancer: new prospects for old challenges
Shen, M. M., & Abate-Shen, C. (2010) · Genes & Development · doi:10.1101/gad.1965810 · Cited by 946
Role of ROS and Nutritional Antioxidants in Human Diseases
Liu, Z., Ren, Z., Zhang, J., Chuang, C.-C., Kandaswamy, E., Zhou, T., & Zuo, L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00477 · Cited by 860
Cross talk between mitochondria and NADPH oxidases
Dikalov, S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.033 · Cited by 783
Metadata
- Authors
- Khandrika, L., Kumar, B., Koul, S., Maroni, P., & Koul, H. K.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 282
- Issue
- 2
- Pages
- 125-136
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2004859816
- Cited by
- 527
- References
- 97
- FWCI
- 10.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.